Diagnostics company targets new markets to aid patient testing

June 20th, 2018

CEO Peter Keeling

Diaceutics, the diagnostic commercialization company that improves patient outcomes via better diagnostic testing, today announces that it has raised $5 million in new mezzanine financing from two partners, WhiteRock Capital Partners* and Silicon Valley Bank. The money will be used to support the organization’s continued global expansion.

Latest Blogs

View all